Discovering Cell Type-Specific Patterns of G Protein-Coupled Receptor Phosphorylation

  • Kok Choi Kong
  • Andrew B. TobinEmail author
  • Adrian J. Butcher
Part of the Neuromethods book series (NM, volume 60)


Phosphorylation of G protein-coupled receptors (GPCRs) occurs within seconds of agonist stimulation and is one of the most prevalent mechanisms through which signalling of this super receptor family is regulated. Although traditionally associated with receptor desensitisation and internalisation, there is an increasing body of evidence that suggests that GPCRs employ phosphorylation as a mechanism of coupling the receptor to non-G protein signalling pathways. Recently, it has become clear that GPCRs can be differentially phosphorylated in different cell types or tissues, possibly by tissue- or cell type-specific employment of a variety of receptor kinases to generate specific “phosphorylation patterns” that might encode signalling properties on the receptor. Although hampered by low levels of expression and high hydrophobicity, GPCR phosphorylation can be studied using various methods including two-dimensional (2D) phosphopeptide mapping, mass spectrometry, production of phospho-specific antibodies and site-directed mutagenesis. In this chapter, we discuss the first three methods which are employed in our laboratory for the studies of M3-muscarinic receptor phosphorylation.

Key words

Antibodies G-protein-coupled receptor Immunoprecipitation Phosphorylation Proteomics 2D phosphopeptide maps SDS-PAGE Mass spectrometry 


  1. 1.
    Pierce KL, Premont RT, Lefkowitz RJ (2002) Seven-transmembrane receptors. Nat Rev Mol Cell Biol 3:639–650.PubMedCrossRefGoogle Scholar
  2. 2.
    Gainetdinov RR, Premont RT, Bohn LM et al (2004) Desensitization of G protein-coupled receptors and neuronal functions. Ann Rev Neurosci 27:107–144.PubMedCrossRefGoogle Scholar
  3. 3.
    Gether U (2000) Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev 21:90–113.PubMedCrossRefGoogle Scholar
  4. 4.
    Drews J (2000) Drug discovery: a historical perspective. Science 287:1960–1964.PubMedCrossRefGoogle Scholar
  5. 5.
    Hopkins AL, Groom CR (2002) The druggable genome. Nat Rev Drug Discov 1:727–730.PubMedCrossRefGoogle Scholar
  6. 6.
    Eglen RM (2006) Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function. Auton Autacoid Pharmacol 26:219–233.PubMedCrossRefGoogle Scholar
  7. 7.
    Eglen RM, Hegde SS, Watson N (1996) Muscarinic receptor subtypes and smooth muscle function. Pharmacol Rev 48:531–565.PubMedGoogle Scholar
  8. 8.
    Wess J, Eglen RM, Gautam D (2007) Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nat Rev Drug Discov 6:721–33.PubMedCrossRefGoogle Scholar
  9. 9.
    Busillo JM, Armando S, Sengupta R et al (2010) Site-specific phosphorylation of CXCR4 is dynamically regulated by multiple kinases and results in differential modulation of CXCR4 signaling. J Biol Chem 285:7805–7817.PubMedCrossRefGoogle Scholar
  10. 10.
    Luo J, Busillo JM, Benovic JL (2008) M3 muscarinic acetylcholine receptor-mediated signaling is regulated by distinct mechanisms. Mol Pharmacol 74:338–347.PubMedCrossRefGoogle Scholar
  11. 11.
    Torrecilla I, Spragg EJ, Poulin B et al (2007) Phosphorylation and regulation of a G protein-coupled receptor by protein kinase CK2. J Cell Biol 177:127–137.PubMedCrossRefGoogle Scholar
  12. 12.
    Tobin AB, Butcher AJ, Kong KC (2008) Location, location, location…site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling. Trends Pharmacol Sci 29:413–420.PubMedCrossRefGoogle Scholar
  13. 13.
    Blaukat A, Pizard A, Breit A et al (2001) Determination of bradykinin B2 receptor in vivo phosphorylation sites and their role in receptor function. J Biol Chem 276:40431–40440.PubMedCrossRefGoogle Scholar
  14. 14.
    Trester-Zedlitz M, Burlingame A, Kobilka B et al (2005) Mass spectrometric analysis of agonist effects on posttranslational modifications of the beta-2 adrenoceptor in mammalian cells. Biochemistry 44:6133–6143.PubMedCrossRefGoogle Scholar
  15. 15.
    Jones BW, Song GJ, Greuber EK et al (2007) Phosphorylation of the endogenous thyrotropin-releasing hormone receptor in pituitary GH3 cells and pituitary tissue revealed by phosphosite-specific antibodies. J Biol Chem 282:12893–12906.PubMedCrossRefGoogle Scholar
  16. 16.
    Tran TM, Friedman J, Qunaibi E et al (2004) Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies. Mol Pharmacol 65:196–206.PubMedCrossRefGoogle Scholar
  17. 17.
    Kara E, Crepieux P, Gauthier C et al (2006) A phosphorylation cluster of five serine and threonine residues in the C-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for beta-arrestin-mediated ERK activation. Mol Endocrinol 20:3014–3026.PubMedCrossRefGoogle Scholar
  18. 18.
    Mendez A, Burns ME, Roca A et al (2000) Rapid and reproducible deactivation of rhodopsin requires multiple phosphorylation sites. Neuron 28:153–164.PubMedCrossRefGoogle Scholar
  19. 19.
    Seibold A, Williams B, Huang ZF et al (2000) Localization of the sites mediating desensitization of the beta(2)-adrenergic receptor by the GRK pathway. Mol Pharmacol 58:1162–1173.PubMedGoogle Scholar
  20. 20.
    Kim KM, Valenzano KJ, Robinson SR et al (2001) Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and beta-arrestins. J Biol Chem 276:37409–37414.PubMedCrossRefGoogle Scholar
  21. 21.
    Nakamura K, Hipkin RW, Ascoli M (1998) The agonist-induced phosphorylation of the rat follitropin receptor maps to the first and third intracellular loops. Mol Endocrinol 12:580–591.PubMedCrossRefGoogle Scholar
  22. 22.
    Paxton WG, Marrero MB, Klein JD et al (1994) The angiotensin II AT1 receptor is tyrosine and serine phosphorylated and can serve as a substrate for the src family of tyrosine kinases. Biochem Biophys Res Commun 200:260–267.PubMedCrossRefGoogle Scholar
  23. 23.
    Benovic JL, Pike LJ, Cerione RA et al (1985) Phosphorylation of the mammalian beta-adrenergic receptor by cyclic AMP-dependent protein kinase. Regulation of the rate of receptor phosphorylation and dephosphorylation by agonist occupancy and effects on coupling of the receptor to the stimulatory guanine nucleotide regulatory protein. J Biol Chem 260:7094–7101.Google Scholar
  24. 24.
    Kristiansen K (2004) Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. Pharmacol Ther 103:21–80.PubMedCrossRefGoogle Scholar
  25. 25.
    Lefkowitz RJ (2004) Historical review: a brief history and personal retrospective of seven-transmembrane receptors. Trends Pharmacol Sci 25:413–422.PubMedCrossRefGoogle Scholar
  26. 26.
    Budd DC, Willars GB, McDonald JE et al (2001) Phosphorylation of the Gq/11-coupled M3-muscarinic receptor is involved in receptor activation of the ERK-1/2 mitogen-activated protein kinase pathway. J Biol Chem 276:4581–4587.PubMedCrossRefGoogle Scholar
  27. 27.
    Doronin S, Shumay E, Wang HY et al (2002) Akt mediates sequestration of the beta(2)-adrenergic receptor in response to insulin. J Biol Chem 277:15124–15131.PubMedCrossRefGoogle Scholar
  28. 28.
    Violin JD, Ren XR, Lefkowitz RJ (2006) G-protein-coupled receptor kinase specificity for beta-arrestin recruitment to the beta2-adrenergic receptor revealed by fluorescence resonance energy transfer. J Biol Chem 281:20577–20588.PubMedCrossRefGoogle Scholar
  29. 29.
    Kim J, Ahn S, Ren XR et al (2005) Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling. Proc Natl Acad Sci USA 102:1442–1447.PubMedCrossRefGoogle Scholar
  30. 30.
    Ren XR, Reiter E, Ahn S et al (2005) Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor. Proc Natl Acad Sci USA 102:1448–1453.PubMedCrossRefGoogle Scholar
  31. 31.
    Willets JM, Challiss RA, Nahorski SR (2002) Endogenous G protein-coupled receptor kinase 6 Regulates M3 muscarinic acetylcholine receptor phosphorylation and desensitization in human SH-SY5Y neuroblastoma cells. J Biol Chem 277:15523–15529.PubMedCrossRefGoogle Scholar
  32. 32.
    Willets JM, Mistry R, Nahorski SR et al (2003) Specificity of G protein-coupled receptor kinase 6-mediated phosphorylation and regulation of single-cell M3 muscarinic acetylcholine receptor signaling. Mol Pharmacol 64:1059–1068.PubMedCrossRefGoogle Scholar
  33. 33.
    Boyle WJ, van der Geer P, Hunter T (1991) Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol 201:110–149.PubMedCrossRefGoogle Scholar
  34. 34.
    Ozcelebi F, Miller LJ (1995) Phosphopeptide mapping of cholecystokinin receptors on agonist-stimulated native pancreatic acinar cells. J Biol Chem 270:3435–3441.PubMedCrossRefGoogle Scholar
  35. 35.
    Lane CS (2005) Mass spectrometry-based proteomics in the life sciences. Cell Mol Life Sci 62:848–869.PubMedCrossRefGoogle Scholar
  36. 36.
    Perkins DN, Pappin DJ, Creasy DM et al (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20:3551–3567.PubMedCrossRefGoogle Scholar
  37. 37.
    Ong S-E, Mann M (2005) Mass spectrometry-based proteomics turns quantitative. Nat Chem Biol 1:252–262.PubMedCrossRefGoogle Scholar
  38. 38.
    Wu S, Birnbaumer M, Guan Z (2008) Phosphorylation analysis of G protein-coupled receptor by mass spectrometry: identification of a phosphorylation site in V2 vasopressin receptor. Anal Chem 80:6034–6037.PubMedCrossRefGoogle Scholar
  39. 39.
    Butcher AJ, Torrecilla I, Young KW et al (2009) N-methyl-D-aspartate receptors mediate the phosphorylation and desensitization of muscarinic receptors in cerebellar granule neurons. J Biol Chem 284:17147–17156.PubMedCrossRefGoogle Scholar
  40. 40.
    Hirai H, Yoshioka K, Yamada K (2000) A simple method using 31P-NMR spectroscopy for the study of protein phosphorylation. Brain Res Brain Res Protoc 5:182–189.PubMedCrossRefGoogle Scholar
  41. 41.
    Ge Y, Peng H, Huang K (2006) 31P NMR study on the autophosphorylation of insulin receptors in the plasma membrane. Anal Bioanal Chem 385:834–839.PubMedCrossRefGoogle Scholar
  42. 42.
    Landrieu I, Lacosse L, Leroy A et al (2006) NMR analysis of a Tau phosphorylation pattern. J Am Chem Soc 128:3575–3583.PubMedCrossRefGoogle Scholar
  43. 43.
    Selenko P, Frueh DP, Elsaesser SJ et al (2008) In situ observation of protein phosphorylation by high-resolution NMR spectroscopy. Nat Struct Mol Biol 15:321–329.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Kok Choi Kong
  • Andrew B. Tobin
    • 1
    Email author
  • Adrian J. Butcher
  1. 1.Department of Cell Physiology and PharmacologyUniversity of LeicesterLeicesterUK

Personalised recommendations